Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Cash & Equivalents (2019 - 2025)

IM Cannabis has reported Cash & Equivalents over the past 7 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $2.0 million for Q4 2025, up 216.54% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 216.54% YoY), and the annual figure for FY2025 was $2.0 million, up 209.64%.
  • Cash & Equivalents for Q4 2025 was $2.0 million at IM Cannabis, up from $617777.8 in the prior quarter.
  • Over the last five years, Cash & Equivalents for IMCC hit a ceiling of $11.0 million in Q4 2021 and a floor of $255971.4 in Q2 2024.
  • Median Cash & Equivalents over the past 5 years was $1.6 million (2022), compared with a mean of $2.8 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 83.64% in 2022 and later skyrocketed 216.54% in 2025.
  • IM Cannabis' Cash & Equivalents stood at $11.0 million in 2021, then plummeted by 83.64% to $1.8 million in 2022, then dropped by 26.19% to $1.3 million in 2023, then crashed by 53.61% to $617777.8 in 2024, then skyrocketed by 216.54% to $2.0 million in 2025.
  • The last three reported values for Cash & Equivalents were $2.0 million (Q4 2025), $617777.8 (Q4 2024), and $255971.4 (Q2 2024) per Business Quant data.